News

Carisma Therapeutics Moves Forward with Dual Delisting Strategy

Carisma Therapeutics Moves Forward with Dual Delisting Strategy

Carisma Therapeutics Initiates Voluntary Delisting from Nasdaq

Carisma Therapeutics Inc. (OTCID: CARM) has made an important announcement regarding its future operations. The company's Board of Directors has approved a voluntary delisting of its common stock from The Nasdaq Stock Market. This decision reflects the company's desire to streamline its reporting obligations under the Securities and Exchange Act of 1934.

Reasons for the Delisting and Deregistration

The decision to proceed with the delisting stems from the company's previous noncompliance with Nasdaq's requirements related to bid prices and market value. Following a determination letter from Nasdaq, which underscored these issues, Carisma decided to take proactive steps to address its financial state. On October 13, 2025, the company’s common stock began trading on the OTCID market, shifting away from Nasdaq under the trading symbol "CARM." This transition showcases the company's adaptive strategy amid ongoing challenges.

The Impact of Delisting

Following the delisting, Carisma plans to file a Form 15 with the SEC to suspend its reporting requirements. By doing so, the company aims to alleviate the considerable burdens associated with sustaining its public company status. The anticipation is that the deregistration will take effect 90 days after this application is submitted, allowing for a more focused approach to winding down its operations.

Strategic Considerations Moving Forward

The Board has carefully weighed the benefits and implications of this decision. Among the factors considered were the timing of the Nasdaq determination letter, the utility of an expedited delisting process, and the overall direction of the company towards an orderly cessation of its operations. The aim is to maximize the company’s remaining resources for the benefit of its stakeholders, ensuring the most favorable outcome possible in a challenging situation.

About Carisma Therapeutics

Carisma Therapeutics has been recognized for its innovative approach to biotechnology, particularly in macrophage engineering aimed at addressing serious health conditions. The company’s vision has focused on developing transformative therapies for diseases such as liver fibrosis and cancer. As Carisma pivots towards winding down its business, its commitment to its mission remains evident.

Future Actions and Stakeholder Impact

In taking these steps, Carisma aims to maintain transparency with its stakeholders while focusing on financial health amidst operational challenges. Shareholders and other interested parties can rest assured that the company will be making its filings accessible through its website, ensuring continued open lines of communication during this transition.

Frequently Asked Questions

What is the reason for Carisma's delisting from Nasdaq?

Carisma's delisting is due to noncompliance with Nasdaq's bid price and market value requirements, leading the company to opt for a voluntary exit.

When did Carisma's common stock begin trading on the OTCID market?

The company's common stock started trading on the OTCID market on October 13, 2025, following its suspension from Nasdaq.

What are the next steps for Carisma following the delisting?

Carisma plans to file a Form 15 with the SEC to suspend its reporting obligations and will also pursue deregistration of its common stock subsequently.

How is Carisma planning to support its stakeholders during this transition?

The company is committed to maintaining transparency and will provide access to its filings on its website, prioritizing stakeholder communication.

What impact does this decision have on Carisma's business operations?

The delisting and deregistration are part of Carisma's strategy to wind down operations responsibly, optimizing its resources and managing liabilities effectively.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Circuit Adds Gabe Klein as Microtransit Expansion Adviser

Updated Category News Views 29

Municipal mobility is a slow, political grind, not a shiny-app contest, and Circuit’s decision to add Gabe Klein to its board looks aimed squarely at that reality. The all-electric microtransit operator has brought aboard somebody who has worked inside the machinery of city government, federal transportation policy, electrification, venture investing, and transportation...

Continue Reading
Exiger's CEO Honored for Military Support Excellence

Updated Category News Views 256

Recognizing Civilian and Military Leadership When you hear "recognition in the military sector," it isn't just a pat on the back. It's a whole parade of brass hats and high-flyers giving their nods. So, November 10th wasn't just any regular day—Brandon Daniels, CEO of Exiger, gets a shiny, prestigious Five-Star Award for his "extraordinary support" of our military...

Continue Reading
Breakthrough T1D Gala Puts Research Progress First

Updated Category News Views 5

One person living without insulin after a cell-therapy trial is the detail that cuts through all the ballroom polish tonight. Breakthrough T1D's 53rd Annual New York City Promise Gala lands at the Plaza Hotel during National Diabetes Awareness Month, and it carries a message worth handling carefully: research can produce extraordinary outcomes, but one participant's...

Continue Reading
LRM Adds Two IND Studies Testing Injectable PDGF in Skin

Updated Category News Views 14

Under-eye medicine has a nasty habit of outrunning the evidence, which makes LRM's decision to put injectable rhPDGF-BB through more formal study worth watching. Lynch Regenerative Medicine has announced two FDA-accepted INDs for investigator-initiated clinical trials: one examining what the material does inside facial skin, the other testing it for infraorbital...

Continue Reading
COPD Support Program Targets a Costly Care Gap Today

Updated Category News Views 129

Breathing trouble gets shrugged off far too easily, and that casual mistake has consequences. World COPD Day puts chronic obstructive pulmonary disease back in view, with the American Lung Association emphasizing a free Lung Health Navigator program for people living with COPD, their caregivers and families. This is not flashy medicine or a miracle-cure pitch. It is...

Continue Reading
Historic China-Russia-US Summit Aims for Global Stability

Updated Category News Views 91

The Weight of History in Shenzhen When the big players decide to talk face-to-face, it's more than just a photo op. This week in Shenzhen, the leaders of China, Russia, and the United States are doing just that. And let me tell you, it's the kind of gathering that can either stabilize the gears of global politics or grease the wheels of tension. This chinwag isn't just...

Continue Reading
Anycubic Pushes Toward a Smoother 3D Printing Ecosystem

Updated Category News Views 51

Friction Is the Enemy in Consumer 3D Printing A printer that makes a beautiful object only after three failed attempts is not a consumer product; it is a weekend argument with plastic. That is the useful lens for Anycubic's Formnext 2026 showing in Frankfurt on November 18. The company is not merely rolling out FDM and resin machines at Booth F01 in Hall 12.0. It is...

Continue Reading
Oracle Takes AI to Construction's Messy Project Middle

Updated Category News Views 157

A stalled drywall inspection can wreck a schedule faster than any glossy AI pitch can repair it. That is the grimy, practical corner Oracle is aiming at with its latest Oracle Primavera Cloud upgrades: the daily hunt for answers, the repeated logging of familiar risks, and the finger-pointing that starts when a milestone is suddenly in danger. This is not a chatbot being...

Continue Reading
Abacus Global Faces Scrutiny Over Accounting Practices

Updated Category News Views 265

Storm Clouds Gather over Abacus Global Management If it ain't one thing, it's another—at least that's what folks holding the bag with Abacus Global (ABX) are thinking right now. News of a pending investigation has dropped like a lead balloon, and the air is thick with scrutiny over their financial dealings. We're jawing about related-party transactions now under the...

Continue Reading
Ampace Fire Test Gives Data Centers Useful Evidence

Updated Category News Views 134

Battery cabinets are becoming the awkward guest in the AI data-center boom: absolutely necessary, expensive to install, and nobody wants to discover their failure behavior during a real emergency. Ampace’s newly presented PU100 large-scale fire-test results deserve attention for that reason. This is not a magic safety stamp, and the company says the findings apply only...

Continue Reading

Top 5 Most Recently Viewed Articles

Jøtul Group's Financial Challenges and Strategic Response

Updated Category News Views 138

Understanding the Jøtul Group's Financial Landscape The Jøtul Group is a major player in the fireplace market, known for its exceptional range of products that cater to various consumer preferences. Founded in 1853, this company proudly represents some of Europe's most reputable brands, including Jøtul, Scan, and Ravelli. Each brand encapsulates a unique design...

Continue Reading
Capri Holdings Limited Faces Legal Scrutiny: What You Need to Know

Updated Category News Views 425

Capri Holdings Limited Under Investigation Capri Holdings Limited, known for its involvement in the luxury fashion sector, has recently come under the spotlight due to an ongoing investigation. This investigation is being led by the Law Offices of Howard G. Smith on behalf of the investors of the company. The core of the inquiry centers around potential violations of...

Continue Reading
eBay's Year-End Performance and 2025 Outlook Highlights

Updated Category News Views 1606

eBay Inc. Financial Performance Overview eBay Inc. has showcased remarkable financial growth in its latest performance report. The company announced substantial revenue figures and gross merchandise volume (GMV) for the last quarter and the full year, reinforcing its position as a leading global commerce platform. Key Financial Highlights of Q4 eBay's revenue reached an...

Continue Reading
Join Us for a Free Webinar on Stepfamily Support Strategies

Updated Category News Views 183

Understanding Stepfamily Dynamics Navigating the complexities of blended families can be challenging, and that is exactly why this free webinar, titled From Conflict to Connection: Navigating Stepfamily Dynamics, offers unparalleled insights for parents and stepparents alike. The event is set to feature expert panelists who specialize in co-parenting and stepfamily...

Continue Reading
Lamb Weston Faces Sharp Decline Amid Nasdaq Rally in Stocks

Updated Category News Views 143

Nasdaq Composite Shows Robust Gains The U.S. stock market experienced a positive trajectory as the Nasdaq Composite surged over 1% on a recent trading day. Investors found motivation in the optimistic outlook surrounding technology shares, which rose by 1.6%. Dow and S&P 500 Performance The Dow Jones Industrial Average reflected a modest uptick of 0.55%, reaching an...

Continue Reading